Meriaura Group Plc: Inside information: Sale of Meriaura’s minority shareholding to Meriaura Invest

Meriaura Group Plc Company announcement, Inside information                                                    2 July 2024 at 15.10 Inside information: Sale of Meriaura’s minority shareholding to Meriaura Invest Referring to the company announcement by Meriaura Group Plc on April 25, 2024, the company’s board has today decided to sell the minority shareholding of

Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®

Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® Two additional studies comparing the pharmacokinetics, safety, and tolerability of AVT03 to Prolia and Xgeva, respectively, have also met their primary endpoint Alvotech expects to file marketing applications for AVT03 later this year for major global

Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®

Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® Two additional studies comparing the pharmacokinetics, safety, and tolerability of AVT03 to Prolia and Xgeva, respectively, have also met their primary endpoint Alvotech expects to file marketing applications for AVT03 later this year for major global

Channel Factory and Ad Fontes Media launch Political Campaign Digital Media Solution focused on brand safe and reliable news content Ahead of the 2024 US Presidential Election

Advertisers will have access to brand safe and suitable news content that was previously excluded together with misleading and fake news CITY OF INDUSTRY, Calif., July 02, 2024 — Channel Factory, the global brand suitability and contextual advertising platform, and Ad Fontes Media, a tech company that rates